In vivo 及In vitro篩選探討抗高血壓藥物是否經SREBP 及PPAR路徑調控脂質代謝，並進而研究以山芹菜子水萃物合併治療改善脂質異常加重腎纖維化的可能性與機制(3/3)

Medicine & Life Sciences

1. Apium 100%
2. Seeds 63%
3. Kidney 60%
4. Antihypertensive Agents 47%
5. Sterol Regulatory Element Binding Proteins 31%
6. Dyslipidemias 30%
7. Peroxisome Proliferator-Activated Receptors 24%
8. 3-n-butylphthalide 17%
9. arabinogalactan 16%
10. Molecular Mechanisms of Pharmacological Action 16%
11. Fibrosis 15%
12. Hypertension 13%
13. Adrenergic Antagonists 12%
14. Renal Hypertension 12%
15. Angiotensin Receptor Antagonists 11%
16. Polyphenols 11%
17. Cricetinae 10%
18. Diuretics 10%
19. Angiotensin-Converting Enzyme Inhibitors 10%
20. Proteinuria 9%
21. Lipid Metabolism 9%
22. Chronic Renal Insufficiency 9%
23. LDL Cholesterol 9%
24. HDL Cholesterol 9%
25. Triglycerides 8%
26. Signal Transduction 8%
27. Cholesterol 7%
28. Homeostasis 7%
29. Cardiovascular Diseases 7%
30. Calcium 7%
31. Lipids 6%
32. Pressure 6%
33. Therapeutics 5%